We are analyzing https://link.springer.com/article/10.1007/s004280100421.

Title:
Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study | Virchows Archiv
Description:
MAGE (Melanoma antigen E) family gene products encompass tumour-associated antigens (TAAs) recognised by human leukocyte antigen (HLA)-restricted specific T-cells. Agents inducing DNA demethylation, an event typically detectable in cellular de-differentiation processes, were shown to induce the expression of MAGE genes. By using a monoclonal antibody specific for MAGE family gene products, we have studied the expression of these TAAs in a group of 144 patients with invasive ductal breast cancers. Immunohistochemical data were correlated with tumour differentiation, lymphatic vessel invasion, oestrogen receptor expression, intratumoural necrosis, lymphocytic infiltration, perineural invasion, tumour microcalcifications and axillary lymph node metastases. MAGE immunoreactivity was undetectable in non-neoplastic cells. In poorly differentiated cancers positive staining was observed in 30/63 cases (47.6%) as compared with 13/51 (25.4%) and 5/30 (16.6%) in moderately and well-differentiated tumours, respectively (P<0.05). In addition, MAGE immunoreactivity was significantly correlated with lymphatic vessel invasion and intratumoural necrosis. Moreover, a significant inverse relationship with oestrogen receptor expression was also observed. However, no significant correlation could be established between MAGE immunoreactivity and defined phenotypic characteristics of tumour infiltrating lymphocytes, including expression of CD3, CD4, CD8, CD20 or granzyme B. Thus, expression of MAGE family gene products in invasive ductal breast cancers appears to be associated with poorly differentiated histological phenotypes. These data support the concept of specific immunotherapy in highly aggressive forms of breast neoplasms. Furthermore, they suggest that MAGE immunoreactivity could represent a tumour marker of potential prognostic relevance.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Social Networks
Photography

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, mage, tumour, expression, breast, cancers, privacy, cookies, content, data, antigen, products, immunoreactivity, information, publish, research, search, tumourassociated, antigens, correlated, invasive, ductal, access, log, journal, virchows, differentiation, immunohistochemical, kavalar, sarcevic, spagnoli, family, gene, specific, invasion, cancer, discover, hospital, university, springer, optional, personal, including, parties, policy, find, track, archiv, inversely, study,

Topics {✒️}

month download article/chapter cellular de-differentiation processes restricted specific t-cells tumour infiltrating lymphocytes privacy choices/manage cookies full article pdf related subjects european economic area scope submit manuscript event typically detectable monoclonal antibody specific defined phenotypic characteristics highly aggressive forms potential prognostic relevance chemotherapeutic drug resistance mage tumour tumour differentiation conditions privacy policy lymphatic vessel invasion oestrogen receptor expression significant inverse relationship intratumoural necrosis tumour microcalcifications tumour marker accepting optional cookies human leukocyte antigen breast neoplasms university hospital basel journal finder publish virchows arch 439 immunohistochemical study article log article kavalar data support information privacy policy article cite including expression books a personal data immunohistochemical data mage immunoreactivity check access research instant access differentiated tumours optional cookies manage preferences specific immunotherapy juretic department

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study
         description: MAGE (Melanoma antigen E) family gene products encompass tumour-associated antigens (TAAs) recognised by human leukocyte antigen (HLA)-restricted specific T-cells. Agents inducing DNA demethylation, an event typically detectable in cellular de-differentiation processes, were shown to induce the expression of MAGE genes. By using a monoclonal antibody specific for MAGE family gene products, we have studied the expression of these TAAs in a group of 144 patients with invasive ductal breast cancers. Immunohistochemical data were correlated with tumour differentiation, lymphatic vessel invasion, oestrogen receptor expression, intratumoural necrosis, lymphocytic infiltration, perineural invasion, tumour microcalcifications and axillary lymph node metastases. MAGE immunoreactivity was undetectable in non-neoplastic cells. In poorly differentiated cancers positive staining was observed in 30/63 cases (47.6%) as compared with 13/51 (25.4%) and 5/30 (16.6%) in moderately and well-differentiated tumours, respectively (P<0.05). In addition, MAGE immunoreactivity was significantly correlated with lymphatic vessel invasion and intratumoural necrosis. Moreover, a significant inverse relationship with oestrogen receptor expression was also observed. However, no significant correlation could be established between MAGE immunoreactivity and defined phenotypic characteristics of tumour infiltrating lymphocytes, including expression of CD3, CD4, CD8, CD20 or granzyme B. Thus, expression of MAGE family gene products in invasive ductal breast cancers appears to be associated with poorly differentiated histological phenotypes. These data support the concept of specific immunotherapy in highly aggressive forms of breast neoplasms. Furthermore, they suggest that MAGE immunoreactivity could represent a tumour marker of potential prognostic relevance.
         datePublished:2014-04-11T00:00:00Z
         dateModified:2014-04-11T00:00:00Z
         pageStart:127
         pageEnd:131
         sameAs:https://doi.org/10.1007/s004280100421
         keywords:
            Breast cancer MAGE immunoreactivity Tumour-associated antigens
            Pathology
         image:
         isPartOf:
            name:Virchows Archiv
            issn:
               1432-2307
               0945-6317
            volumeNumber:439
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:R. Kavalar
               affiliation:
                     name:Maribor General Hospital, Maribor
                     address:
                        name:Maribor General Hospital, Maribor, Slovenia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. Sarcevic
               affiliation:
                     name:University Hospital for Tumours, Zagreb
                     address:
                        name:University Hospital for Tumours, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Spagnoli
               affiliation:
                     name:Department of Surgery, Division of Research, University Hospital Basel
                     address:
                        name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:V. Separovic
               affiliation:
                     name:University Hospital for Tumours, Zagreb
                     address:
                        name:University Hospital for Tumours, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Samija
               affiliation:
                     name:University Hospital for Tumours, Zagreb
                     address:
                        name:University Hospital for Tumours, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. Terracciano
               affiliation:
                     name:Department of Pathology, University of Basel
                     address:
                        name:Department of Pathology, University of Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Heberer
               affiliation:
                     name:Department of Surgery, Division of Research, University Hospital Basel
                     address:
                        name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Juretic
               affiliation:
                     name:University Hospital for Tumours, Zagreb
                     address:
                        name:University Hospital for Tumours, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study
      description: MAGE (Melanoma antigen E) family gene products encompass tumour-associated antigens (TAAs) recognised by human leukocyte antigen (HLA)-restricted specific T-cells. Agents inducing DNA demethylation, an event typically detectable in cellular de-differentiation processes, were shown to induce the expression of MAGE genes. By using a monoclonal antibody specific for MAGE family gene products, we have studied the expression of these TAAs in a group of 144 patients with invasive ductal breast cancers. Immunohistochemical data were correlated with tumour differentiation, lymphatic vessel invasion, oestrogen receptor expression, intratumoural necrosis, lymphocytic infiltration, perineural invasion, tumour microcalcifications and axillary lymph node metastases. MAGE immunoreactivity was undetectable in non-neoplastic cells. In poorly differentiated cancers positive staining was observed in 30/63 cases (47.6%) as compared with 13/51 (25.4%) and 5/30 (16.6%) in moderately and well-differentiated tumours, respectively (P<0.05). In addition, MAGE immunoreactivity was significantly correlated with lymphatic vessel invasion and intratumoural necrosis. Moreover, a significant inverse relationship with oestrogen receptor expression was also observed. However, no significant correlation could be established between MAGE immunoreactivity and defined phenotypic characteristics of tumour infiltrating lymphocytes, including expression of CD3, CD4, CD8, CD20 or granzyme B. Thus, expression of MAGE family gene products in invasive ductal breast cancers appears to be associated with poorly differentiated histological phenotypes. These data support the concept of specific immunotherapy in highly aggressive forms of breast neoplasms. Furthermore, they suggest that MAGE immunoreactivity could represent a tumour marker of potential prognostic relevance.
      datePublished:2014-04-11T00:00:00Z
      dateModified:2014-04-11T00:00:00Z
      pageStart:127
      pageEnd:131
      sameAs:https://doi.org/10.1007/s004280100421
      keywords:
         Breast cancer MAGE immunoreactivity Tumour-associated antigens
         Pathology
      image:
      isPartOf:
         name:Virchows Archiv
         issn:
            1432-2307
            0945-6317
         volumeNumber:439
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:R. Kavalar
            affiliation:
                  name:Maribor General Hospital, Maribor
                  address:
                     name:Maribor General Hospital, Maribor, Slovenia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. Sarcevic
            affiliation:
                  name:University Hospital for Tumours, Zagreb
                  address:
                     name:University Hospital for Tumours, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Spagnoli
            affiliation:
                  name:Department of Surgery, Division of Research, University Hospital Basel
                  address:
                     name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:V. Separovic
            affiliation:
                  name:University Hospital for Tumours, Zagreb
                  address:
                     name:University Hospital for Tumours, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Samija
            affiliation:
                  name:University Hospital for Tumours, Zagreb
                  address:
                     name:University Hospital for Tumours, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. Terracciano
            affiliation:
                  name:Department of Pathology, University of Basel
                  address:
                     name:Department of Pathology, University of Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Heberer
            affiliation:
                  name:Department of Surgery, Division of Research, University Hospital Basel
                  address:
                     name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Juretic
            affiliation:
                  name:University Hospital for Tumours, Zagreb
                  address:
                     name:University Hospital for Tumours, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Virchows Archiv
      issn:
         1432-2307
         0945-6317
      volumeNumber:439
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Maribor General Hospital, Maribor
      address:
         name:Maribor General Hospital, Maribor, Slovenia
         type:PostalAddress
      name:University Hospital for Tumours, Zagreb
      address:
         name:University Hospital for Tumours, Zagreb, Croatia
         type:PostalAddress
      name:Department of Surgery, Division of Research, University Hospital Basel
      address:
         name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
         type:PostalAddress
      name:University Hospital for Tumours, Zagreb
      address:
         name:University Hospital for Tumours, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital for Tumours, Zagreb
      address:
         name:University Hospital for Tumours, Zagreb, Croatia
         type:PostalAddress
      name:Department of Pathology, University of Basel
      address:
         name:Department of Pathology, University of Basel, Switzerland
         type:PostalAddress
      name:Department of Surgery, Division of Research, University Hospital Basel
      address:
         name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
         type:PostalAddress
      name:University Hospital for Tumours, Zagreb
      address:
         name:University Hospital for Tumours, Zagreb, Croatia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:R. Kavalar
      affiliation:
            name:Maribor General Hospital, Maribor
            address:
               name:Maribor General Hospital, Maribor, Slovenia
               type:PostalAddress
            type:Organization
      name:B. Sarcevic
      affiliation:
            name:University Hospital for Tumours, Zagreb
            address:
               name:University Hospital for Tumours, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:G. Spagnoli
      affiliation:
            name:Department of Surgery, Division of Research, University Hospital Basel
            address:
               name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:V. Separovic
      affiliation:
            name:University Hospital for Tumours, Zagreb
            address:
               name:University Hospital for Tumours, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:M. Samija
      affiliation:
            name:University Hospital for Tumours, Zagreb
            address:
               name:University Hospital for Tumours, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:L. Terracciano
      affiliation:
            name:Department of Pathology, University of Basel
            address:
               name:Department of Pathology, University of Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:M. Heberer
      affiliation:
            name:Department of Surgery, Division of Research, University Hospital Basel
            address:
               name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:A. Juretic
      affiliation:
            name:University Hospital for Tumours, Zagreb
            address:
               name:University Hospital for Tumours, Zagreb, Croatia
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Maribor General Hospital, Maribor, Slovenia
      name:University Hospital for Tumours, Zagreb, Croatia
      name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
      name:University Hospital for Tumours, Zagreb, Croatia
      name:University Hospital for Tumours, Zagreb, Croatia
      name:Department of Pathology, University of Basel, Switzerland
      name:Department of Surgery, Division of Research, University Hospital Basel, Switzerland
      name:University Hospital for Tumours, Zagreb, Croatia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(39)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.92s.

LINK . SPRINGER . COM {}